206 related articles for article (PubMed ID: 20413677)
1. Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
Earle JS; Luthra R; Romans A; Abraham R; Ensor J; Yao H; Hamilton SR
J Mol Diagn; 2010 Jul; 12(4):433-40. PubMed ID: 20413677
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancers with microsatellite instability display unique miRNA profiles.
Balaguer F; Moreira L; Lozano JJ; Link A; Ramirez G; Shen Y; Cuatrecasas M; Arnold M; Meltzer SJ; Syngal S; Stoffel E; Jover R; Llor X; Castells A; Boland CR; Gironella M; Goel A
Clin Cancer Res; 2011 Oct; 17(19):6239-49. PubMed ID: 21844009
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation-mediated repression of miR-181a/135a/302c expression promotes the microsatellite-unstable colorectal cancer development and 5-FU resistance via targeting PLAG1.
Shi L; Li X; Wu Z; Li X; Nie J; Guo M; Mei Q; Han W
J Genet Genomics; 2018 Apr; 45(4):205-214. PubMed ID: 29735329
[TBL] [Abstract][Full Text] [Related]
4. Relationship between
Proença MA; Biselli JM; Succi M; Severino FE; Berardinelli GN; Caetano A; Reis RM; Hughes DJ; Silva AE
World J Gastroenterol; 2018 Dec; 24(47):5351-5365. PubMed ID: 30598580
[TBL] [Abstract][Full Text] [Related]
5. miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer.
Ma Y; Zhang P; Wang F; Zhang H; Yang J; Peng J; Liu W; Qin H
Gut; 2012 Oct; 61(10):1447-53. PubMed ID: 22052060
[TBL] [Abstract][Full Text] [Related]
6. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.
Ozcan O; Kara M; Yumrutas O; Bozgeyik E; Bozgeyik I; Celik OI
Tumour Biol; 2016 May; 37(5):6637-45. PubMed ID: 26643896
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA and targeted mRNA expression profiling analysis in human colorectal adenomas and adenocarcinomas.
Gattolliat CH; Uguen A; Pesson M; Trillet K; Simon B; Doucet L; Robaszkiewicz M; Corcos L
Eur J Cancer; 2015 Feb; 51(3):409-20. PubMed ID: 25586944
[TBL] [Abstract][Full Text] [Related]
8. Elevated microRNA-23a Expression Enhances the Chemoresistance of Colorectal Cancer Cells with Microsatellite Instability to 5-Fluorouracil by Directly Targeting ABCF1.
Li X; Li X; Liao D; Wang X; Wu Z; Nie J; Bai M; Fu X; Mei Q; Han W
Curr Protein Pept Sci; 2015; 16(4):301-9. PubMed ID: 25929864
[TBL] [Abstract][Full Text] [Related]
9. High microRNA-28-5p expression in colorectal adenocarcinoma predicts short-term relapse of node-negative patients and poor overall survival of patients with non-metastatic disease.
Tsiakanikas P; Kontos CK; Kerimis D; Papadopoulos IN; Scorilas A
Clin Chem Lab Med; 2018 May; 56(6):990-1000. PubMed ID: 29688883
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic characteristics of colorectal cancer with microsatellite instability.
Ziadi S; Ksiaa F; Ben Gacem R; Labaied N; Mokni M; Trimeche M
Pathol Res Pract; 2014 Feb; 210(2):98-104. PubMed ID: 24286815
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analyses of microRNA and mRNA expression in colorectal serrated lesions and colorectal cancer with a microsatellite instability phenotype.
Sugai T; Osakabe M; Niinuma T; Eizuka M; Tanaka Y; Yamada S; Yanagawa N; Otsuka K; Sasaki A; Matsumoto T; Suzuki H
Genes Chromosomes Cancer; 2022 Mar; 61(3):161-171. PubMed ID: 34846081
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of microRNAs-155 and 21 targeting mismatch repair proteins in inflammatory bowel diseases.
Svrcek M; El-Murr N; Wanherdrick K; Dumont S; Beaugerie L; Cosnes J; Colombel JF; Tiret E; Fléjou JF; Lesuffleur T; Duval A
Carcinogenesis; 2013 Apr; 34(4):828-34. PubMed ID: 23288924
[TBL] [Abstract][Full Text] [Related]
13. The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis.
Ling H; Pickard K; Ivan C; Isella C; Ikuo M; Mitter R; Spizzo R; Bullock M; Braicu C; Pileczki V; Vincent K; Pichler M; Stiegelbauer V; Hoefler G; Almeida MI; Hsiao A; Zhang X; Primrose J; Packham G; Liu K; Bojja K; Gafà R; Xiao L; Rossi S; Song JH; Vannini I; Fanini F; Kopetz S; Zweidler-McKay P; Wang X; Ionescu C; Irimie A; Fabbri M; Lanza G; Hamilton SR; Berindan-Neagoe I; Medico E; Mirnezami A; Calin GA; Nicoloso MS
Gut; 2016 Jun; 65(6):977-989. PubMed ID: 25804630
[TBL] [Abstract][Full Text] [Related]
14. A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer.
Maminezhad H; Ghanadian S; Pakravan K; Razmara E; Rouhollah F; Mossahebi-Mohammadi M; Babashah S
Life Sci; 2020 Oct; 258():118226. PubMed ID: 32771555
[TBL] [Abstract][Full Text] [Related]
15. Small RNA expression from viruses, bacteria and human miRNAs in colon cancer tissue and its association with microsatellite instability and tumor location.
Mjelle R; Sjursen W; Thommesen L; Sætrom P; Hofsli E
BMC Cancer; 2019 Feb; 19(1):161. PubMed ID: 30786859
[TBL] [Abstract][Full Text] [Related]
16. High expression of miR-181c as a predictive marker of recurrence in stage II colorectal cancer.
Yamazaki N; Koga Y; Taniguchi H; Kojima M; Kanemitsu Y; Saito N; Matsumura Y
Oncotarget; 2017 Jan; 8(4):6970-6983. PubMed ID: 28036302
[TBL] [Abstract][Full Text] [Related]
17. Microsatellite instability: an update.
Yamamoto H; Imai K
Arch Toxicol; 2015 Jun; 89(6):899-921. PubMed ID: 25701956
[TBL] [Abstract][Full Text] [Related]
18. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.
Brunet Vega A; Pericay C; Moya I; Ferrer A; Dotor E; Pisa A; Casalots À; Serra-Aracil X; Oliva JC; Ruiz A; Saigí E
Oncol Rep; 2013 Jul; 30(1):320-6. PubMed ID: 23673725
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs expression profiling in Egyptian colorectal cancer patients.
Bader El Din NG; Ibrahim MK; El-Shenawy R; Salum GM; Farouk S; Zayed N; Khairy A; El Awady M
IUBMB Life; 2020 Feb; 72(2):275-284. PubMed ID: 31512372
[TBL] [Abstract][Full Text] [Related]
20. Histologic features distinguish microsatellite-high from microsatellite-low and microsatellite-stable colorectal carcinomas, but do not differentiate germline mutations from methylation of the MLH1 promoter.
Yearsley M; Hampel H; Lehman A; Nakagawa H; de la Chapelle A; Frankel WL
Hum Pathol; 2006 Jul; 37(7):831-8. PubMed ID: 16784982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
